InvestorsHub Logo
Post# of 253155
Next 10
Followers 6
Posts 1313
Boards Moderated 0
Alias Born 11/02/2003

Re: None

Friday, 10/31/2014 6:11:22 AM

Friday, October 31, 2014 6:11:22 AM

Post# of 253155
SGEN report was well received by the pre-market.
(Does the tag at the end mean the piece was untouched by human hand?)

BOTHELL, Wash. (AP) _ Seattle Genetics Inc. (SGEN) on Thursday reported a third-quarter loss of $15.6 million.

On a per-share basis, the Bothell, Washington-based company said it had a loss of 13 cents.

The results beat Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The biotechnology company posted revenue of $75.9 million in the period, also exceeding Street forecasts. Analysts expected $66.7 million, according to Zacks.

Seattle Genetics shares have decreased 12 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $35.25, a decline of 12 percent in the last 12 months.

_____

This story was generated by Automated Insights using data from Zacks Investment Research. SGEN stock research report from Zacks.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.